J9150 HCPCS Level II code: Injection, daunorubicin, 10 mg
J9150 is the HCPCS code for “Injection, daunorubicin, 10 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9150Injection, daunorubicin, 10 mg
Short description: Daunorubicin injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J9150 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jan 1, 1986
Where J9150 sits
- 1J codesDrugs administered other than orally
- 2Active code J9150Injection, daunorubicin, 10 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9150 mean?
J9150 is the HCPCS code for “Injection, daunorubicin, 10 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9150?
CMS lists J9150’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9150
All J codesJ9118Injection, calaspargase pegol-mknl, 10 unitsJ9119Injection, cemiplimab-rwlc, 1 mgJ9120Injection, dactinomycin, 0.5 mgJ9130Dacarbazine, 100 mgJ9144Injection, daratumumab, 10 mg and hyaluronidase-fihjJ9145Injection, daratumumab, 10 mgJ9151Injection, daunorubicin citrate, liposomal formulation, 10 mgJ9153Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabineJ9155Injection, degarelix, 1 mgJ9160Injection, denileukin diftitox, 300 microgramsJ9161Injection, denileukin diftitox-cxdl, 1 mcgJ9165Injection, diethylstilbestrol diphosphate, 250 mg